-
公开(公告)号：US09726676B2
公开(公告)日：2017-08-08
申请号：US13825729
申请日：2011-09-20
申请人： Niels Grabe , Niels Halama , Dirk Jaeger , Inka Zoernig
发明人： Niels Grabe , Niels Halama , Dirk Jaeger , Inka Zoernig
IPC分类号： G01N33/68 , G01N33/50 , G01N33/574
CPC分类号： G01N33/6893 , G01N33/5011 , G01N33/5091 , G01N33/574 , G01N2333/7051 , G01N2333/70517 , G01N2333/96436 , G01N2800/52
摘要： The present invention relates to the field of treatment efficacy prediction in patients with malignant diseases. More precisely, this invention relates to the prediction of the efficacy of a treatment in cancer patients, based on the precise quantification of several biological markers that are related to the innate and adaptive immune response of said patient against said cancer.
-
2.发明申请MEANS AND METHODS FOR THE PREDICTION OF TREATMENT RESPONSE OF A CANCER PATIENT 审中-公开预防癌症患者治疗反应的手段和方法公开(公告)号：US20130330325A1
公开(公告)日：2013-12-12
申请号：US13825729
申请日：2011-09-20
申请人： Niels Grabe , Niels Halama
发明人： Niels Grabe , Niels Halama
CPC分类号： G01N33/6893 , G01N33/5011 , G01N33/5091 , G01N33/574 , G01N2333/7051 , G01N2333/70517 , G01N2333/96436 , G01N2800/52
摘要： The present invention relates to the field of treatment efficacy prediction in patients with malignant diseases. More precisely, this invention relates to the prediction of the efficacy of a treatment in cancer patients, based on the precise quantification of several biological markers that are related to the innate and adaptive immune response of said patient against said cancer.
摘要翻译： 本发明涉及恶性疾病患者的治疗功效预测领域。 更准确地说，本发明涉及基于与所述患者针对所述癌症的先天和适应性免疫应答有关的若干生物标志物的精确定量，预测癌症患者的治疗效果。
-
搜索结果
2 条记录 (耗时 0.018 秒)
